Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V6 Oral Vaccine for Atherosclerosis
NCT03042741Phase 3Unknown
- Sponsor
- Immunitor Inc.
- Start
- Feb 2017
- Primary completion
- Dec 2019
- Modality
- Drug Delivery Systems, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of clotrimazole in atherosclerosis, sponsored by Immunitor Inc.. Status: unknown.
02
Drugs
clotrimazole
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT03042741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03042741.